Hospitalized patients with COPD: Analysis of prior treatment;Pacientes portadores de DPOC hospitalizados: Análise do tratamento prévio

Jornal Brasileiro de Pneumologia

Volumn 40, Issue 3, 2014, Pages 229-237

  Giacomelli, Irai Luis ^a   Steidle, Leila John Marques ^a   Moreira, Frederico Fernandes ^a   Meyer, Igor Varela ^a   Souza, Ricardo Goetten ^a   Pincelli, Mariângela Pimentel ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

Author keywords

Chronic obstructive prevention and control; Chronic obstructive therapy; Clinical protocols; Pulmonary disease

Indexed keywords

AGED; BRAZIL; CLINICAL PRACTICE; CLINICAL PROTOCOL; CROSS-SECTIONAL STUDY; FEMALE; HOSPITALIZATION; HUMAN; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUESTIONNAIRE; SOCIOECONOMICS; SPIROMETRY;

AGED; BRAZIL; CLINICAL PROTOCOLS; CROSS-SECTIONAL STUDIES; FEMALE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUESTIONNAIRES; SOCIOECONOMIC FACTORS; SPIROMETRY;

EID: 84904395759     PISSN: 18063713     EISSN: 18063756     Source Type: Journal    
DOI: 10.1590/S1806-37132014000300005     Document Type: Article

References (23)

1. Global Initiative for Chronic Obstructive Lung Disease-GOLD [homepage on the Internet]. Bethesda: Global Initiative for Chronic Obstructive Lung Disease [cited 2011 Dec 26]. Global Strategy for the Diagnosis, Management, and Prevention of COPD-Revised 2011. [Adobe Acrobat document, 90p.]. Available from: http://www. goldcopd. org/uploads/users/files/GOLD_Report_2011_Feb21. pdf.
2. Menezes AM, Perez-Padilla R, Jardim JR, Mui-o A, Lopez MV, Valdivia G, et al. Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study. Lancet. 2005; 366(9500): 1875-81. http://dx. doi. org/10. 1016/S0140-6736(05)67632-5.
3. Sociedade Brasileira de Pneumologia e Tisiologia. II Consenso Brasileiro de Doença Pulmonar Obstrutiva Crônica (DPOC)-2004. J Bras Pneumol. 2004; 30(5): 1-42.
4. Queiroz MC, Moreira MA, Rabahi MF. Underdiagnosis of COPD at primary health care clinics in the city of Aparecida de Goiânia, Brazil. J Bras Pneumol. 2012; 38(6): 692-9. http://dx. doi. org/10. 1590/S1806-37132012000600003.
5. Menezes AM, Macedo SE, Noal RB, Fiterman JC, Cukier A, Chatikin JM, et al. Pharmacological treatment of COPD. J Bras Pneumol. 2011; 37(4): 527-43. http://dx. doi. org/10. 1590/S1806-37132011000400016.
6. Parker CM, Voduc N, Aaron SD, Webb KA, O'Donnell DE. Physiological changes during symptom recovery form moderate exacerbations of COPD. Eur Respir J. 2005; 26(3): 420-8. http://dx. doi. org/10. 1183/09031936. 05. 00136304.
7. Barberà JA, Roca J, Ferrer A, Félez MA, Díaz O, Roger N, et al. Mechanisms of worsening gas exchange during acute exacerbations of chronic obstructive pulmonary disease. Eur Respir J. 1997; 10(6): 1285-91. http://dx. doi. org/10. 1183/09031936. 97. 10061285.
8. Brasil. Ministério da Saúde. Secretaria de Políticas de Saúde. Departamento de Atenção Básica. Doenças respiratórias crônicas. Cadernos de atenção básica no 25. Brasília: Ministério da Saúde; 2010.
9. Aisanov Z, Bai C, Bauerle O, Colodenco FD, Feldman C, Hashimoto S, et al. Primary care physician perceptions on the diagnosis and management of chronic obstructive pulmonary disease in diverse regions of the world. Int J Chron Obstruct Pulmon Dis. 2012; 7: 271-82.
10. Pincelli MP, Grumann AC, Fernandes C, Cavalheiro AG, Haussen DA, Maia IS. Characteristics of COPD patients admitted to the ICU of a referral hospital for respiratory diseases in Brazil. J Bras Pneumol. 2011; 37(2): 217-22.
11. Donner CF, Virchow JC, Lusuardi M. Pharmacoeconomics in COPD and inappropriateness of diagnostics, management and treatment. Respir Med. 2011; 105(6): 828-37. http://dx. doi. org/10. 1016/j. rmed. 2010. 12. 017.
12. Price L, Billups SJ, Rice MA, Hartsfield C. Investigation of barriers to clinical practice guideline-recommended pharmacotherapy in the treatment of COPD. Pharmacy Practice. 2007; 5(2): 74-7.
13. Chung KF, Caramori G, Adcock IM. Inhaled corticosteroids as combination therapy with beta-adrenergic agonists in airways disease: present and future. Eur J Clin Pharmacol. 2009; 65(9): 853-71. http://dx. doi. org/10. 1007/s00228-009-0682-z.
14. Clark DJ, Grove A, Cargill RI, Lipworth BJ. Comparative adrenal suppression with inhaled budesonide and fluticasone propionate in adult asthmatic patients. Thorax. 1996; 51(3): 262-6. http://dx. doi. org/10. 1136/thx. 51. 3. 262.
15. Calverley P, Pauwels R, Vestbo J, Jones P, Pride N, Gulsvik A, et al. Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomized controlled trial. Lancet. 2003; 361(9356): 449-56. http://dx. doi. org/10. 1016/S0140-6736(03)12459-2.
16. Ernst P, Gonzalez AV, Brassard P, Suissa S. Inhaled corticosteroid use in chronic obstructive pulmonary disease and the risk of hospitalization for pneumonia. Am J Respir Crit Care Med. 2007; 176(2): 162-6. http://dx. doi. org/10. 1164/rccm. 200611-1630OC.
17. Glaab T, Banik N, Rutschmann OT, Wencker M. National survey of guideline-compliant COPD management among pneumologists and primary care physicians. COPD. 2006; 3(3): 141-8. http://dx. doi. org/10. 1080/15412550600829299.
18. Rutschmann OT, Janssens JP, Vermeulen B, Sarasin FP. Knowledge of guidelines for the management of COPD: a survey of primary care physicians. Respir Med. 2004; 98(10): 932-7. http://dx. doi. org/10. 1016/j. rmed. 2004. 03. 018.
19. Jones RC, Dickson-Spillmann M, Mather MJ, Marks D, Shackell BS. Accuracy of diagnostic registers and management of chronic obstructive pulmonary disease: the Devon primary care audit. Respir Res. 2008; 9: 62. http://dx. doi. org/10. 1186/1465-9921-9-62.
20. Bourbeau J, Sebalt RJ, Day A, Bouchard J, Kaplan A, Hernandez P, et al. Practice patterns in the management of chronic obstructive pulmonary disease in primary practice: the CAGE study. Can Respir J. 2008; 15(1): 13-9.
21. Decramer M, Celli B, Kesten S, Lystig T, Mehra S, Tashkin DP, et al. Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomized controlled trial. Lancet. 2009; 374(9696): 1171-8. http://dx. doi. org/10. 1016/S0140-6736(09)61298-8.
22. Tashkin DP, Celli B, Senn S, Burkhart D, Kesten S, Menjoge S, et al. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med. 2008; 359(15): 1543-54. http://dx. doi. org/10. 1056/NEJMoa0805800.
23. Portal da Saúde [homepage on the Internet]. Brasília: Ministério da Saúde [cited 2012 Nov 13]. Protocolo clínico e diretrizes terapêuticas doença pulmonar obstrutiva crônica. Available from: http://portal. saude. gov. br/portal/saude/profissional/visualizar_texto. cfm?idtxt=35115.